Tuesday, August 17, 2021 7:17:19 AM
Recent DMAC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:34:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:30:55 PM
- DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results • Business Wire • 05/08/2024 08:30:00 PM
- DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 • Business Wire • 05/02/2024 12:55:00 PM
- DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke • Business Wire • 04/17/2024 08:08:00 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results • Business Wire • 03/19/2024 08:15:00 PM
- DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference • Business Wire • 01/29/2024 09:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:23:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:12:31 PM
- DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer • Business Wire • 01/22/2024 01:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:47:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:39:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:30:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:37:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:55:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:52:34 PM
- DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results • Business Wire • 11/13/2023 09:28:00 PM
- DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023 • Business Wire • 11/09/2023 01:25:00 PM
- DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023 • Business Wire • 11/06/2023 01:23:00 PM
- DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer • Business Wire • 09/12/2023 12:13:00 PM
- DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference • Business Wire • 09/06/2023 12:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:15:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:29:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:25:12 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM